Related Experiment Videos
Activation of protein kinase-C inhibits vitamin D receptor gene expression
1Division of Endocrinology, Stanford University School of Medicine, California 94305.
Abstract:
The abundance of 1,25-dihydroxyvitamin D3 receptors (VDR) in cultured cells has been shown to vary in direct relation to the rate of cell proliferation. This study examines the question of whether the growth-factor mediated up-regulation of VDR is due to direct modulation of VDR gene expression or is secondary to the stimulation of cell cycle events. Mitogenic agents, such as basic fibroblast growth factor and phorbol esters, were found to cause significant decreases in VDR abundance, while substantially stimulating proliferation of NIH-3T3 cells. Potent phorbol esters, such as phorbol myristate acetate (PMA) and phorbol-12,13-dibutyrate, whose biological actions have been shown to be mediated through the activation of protein kinase-C, down-regulated VDR in a time- and dose-dependent manner. An inactive phorbol ester, 4 alpha-phorbol-12,13-didecanoate, which does not activate protein kinase-C, did not alter VDR levels. Desensitization of protein kinase-C by prolonged exposure of cells to phorbol esters eliminated the PMA-mediated down-regulation of VDR. Staurosporine, an inhibitor of protein kinase-C, blocked the actions of PMA. Oleoyl acetyl glycerol, a synthetic diacyl glycerol, and A23187, a calcium ionophore, were both able to suppress VDR abundance alone and were additive in combination. The results suggest that activation of the protein kinase-C pathway and elevation of intracellular Ca2+ lead to significant down-regulation of VDR. The inhibitory effect of PMA appears to be exerted at the level of VDR mRNA expression. Northern blot analysis revealed significant decreases in steady state levels of VDR mRNA species that qualitatively corresponded to the decrease in VDR protein concentration seen on a Western blot.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Growth factors decrease 1,25-dihydroxyvitamin D3 receptors (VDR) by activating protein kinase-C and increasing intracellular calcium. This leads to reduced VDR gene expression and protein levels, impacting cell proliferation.
Area of Science:
- Cell Biology
- Molecular Endocrinology
- Biochemistry
Background:
- 1,25-dihydroxyvitamin D3 receptors (VDR) abundance correlates with cell proliferation rates.
- The mechanism of growth-factor mediated VDR regulation is unclear, potentially involving direct gene modulation or cell cycle stimulation.
Purpose of the Study:
- To investigate whether growth-factor mediated VDR up-regulation is due to direct VDR gene expression modulation or secondary to cell cycle events.
- To elucidate the signaling pathways involved in VDR abundance changes.
Main Methods:
- NIH-3T3 cells were treated with mitogenic agents like basic fibroblast growth factor and phorbol esters.
- Protein kinase-C activation was modulated using phorbol esters (PMA, phorbol myristate acetate), inactive phorbol esters, staurosporine, oleoyl acetyl glycerol, and A23187.
- VDR protein levels were assessed using Western blots, and VDR mRNA levels were analyzed via Northern blot.
Main Results:
- Mitogenic agents significantly decreased VDR abundance while stimulating proliferation.
- Phorbol myristate acetate (PMA) down-regulated VDR in a time- and dose-dependent manner, mediated by protein kinase-C activation.
- Activation of protein kinase-C and elevated intracellular calcium suppressed VDR abundance, affecting VDR mRNA expression.
Conclusions:
- Activation of the protein kinase-C pathway and increased intracellular calcium levels significantly down-regulate VDR.
- The inhibitory effect on VDR is exerted at the level of VDR mRNA expression.
- VDR down-regulation by PMA is linked to protein kinase-C signaling and intracellular calcium elevation.